Dr Reddy's Laboratories was down 1.91% to Rs 2,512.85 at 13:41 IST on BSE after consolidated net profit fell 39.13% to Rs 294.20 crore on 2.97% growth in total revenue from operations to Rs 3834.10 crore in Q3 December 2017 over Q3 December 2016.
The result was announced during market hours today, 25 January 2018.Meanwhile, the S&P BSE Sensex was down 231.97 points or 0.64% at 35,929.67.
On the BSE, 1.21 lakh shares were traded on the counter so far as against average daily volumes of 53,010 shares in the past one quarter. The stock had hit a high of Rs 2,594.95 and a low of Rs 2,458.95 so far during the day. The stock had hit a 52-week high of Rs 3,175 on 6 February 2017 and a 52-week low of Rs 1,901.65 on 11 August 2017.
The large-cap company has equity capital of Rs 82.95 crore. Face value per share is Rs 5.
Dr Reddy's Laboratories is an integrated global pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
